Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02094352 · ClinicalTrials.gov registry record · Phase 2
Randomized Controlled Trial of Ketamine Infusion With Continuous Epidural Infusion for Treatment of Complex Regional Pain Syndrome
A Phase 2 study, sponsored by Hospital for Special Surgery, New York.
- Terminated
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT02094352: Clinical Trial Phase 2 study, sponsored by Hospital for Special Surgery, New York.
NCT02094352 is a Phase 2 study that was terminated before completion, run by Hospital for Special Surgery, New York. The registered enrollment target is 3 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02094352, a Phase 2 study, was terminated before completion, sponsored by Hospital for Special Surgery, New York.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether epidural and ketamine infusions are effective in the treatment of Complex Regional Pain Syndrome (CRPS).
Primary Outcome
Evidence of changes in NRS pain scores between baseline and six months post infusion
Interventions
- DRUG Ketamine Infusion + Epidural Infusion
- DRUG Control Group + Epidural infusion
- DRUG Ketamine Booster Infusion
- DRUG Control Group Booster Infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2014-03-24 |
| Est. Completion | 2015-04-20 |
| Phase | Phase 2 |
Why NCT02094352 stopped before completion
NCT02094352 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 4 interventions - of which Ketamine Infusion + Epidural Infusion is the first listed.
NCT02094352 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02094352 about?
NCT02094352 is a clinical study titled "Randomized Controlled Trial of Ketamine Infusion With Continuous Epidural Infusion for Treatment of Complex Regional Pain Syndrome". The purpose of this study is to determine whether epidural and ketamine infusions are effective in the treatment of Complex Regional Pain Syndrome (CRPS).
What is the current status of trial NCT02094352?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2014-03-24. Estimated completion is 2015-04-20.
What interventions are being tested in trial NCT02094352?
The interventions under investigation include: Ketamine Infusion + Epidural Infusion (DRUG), Control Group + Epidural infusion (DRUG), Ketamine Booster Infusion (DRUG), Control Group Booster Infusion (DRUG).
Who is sponsoring clinical trial NCT02094352?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02094352's enrollment target sits among peer trials
3 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI